How Accredo’s field nurses enable patients to receive complex therapies without leaving home
In addition to employing more than 800 specialty pharmacists who are just a phone call away, Accredo fields a team of about 600 nurses who care for patients in their homes.
Read MoreHow Accredo’s specialty pharmacists support patients with highly complex conditions
Accredo employs more than 800 specialty pharmacists who are dedicated to educating and assisting patients with rare or complex conditions.
Read MorePodcast: Navigating the rising demand for specialty drugs
In this episode of the Health Unscripted Podcast, Matt Perlberg, president of the Evernorth Health Services pharmacy businesses, sits down with Vicki Wheeler, chief operating officer of Evernorth's ph...
Read MoreWhat are drug rebates? Revealing how they work and the value they bring
Working with the complex drug supply chain in the United States, PBMs like Express Scripts help drive competition to lower costs and combat the high price of prescription medications. In doing so, we ...
Read MoreClinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MoreThe importance of utilization management within the medical benefit
The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreInvesting in the next generation of diverse technology talent at Evernorth
To create a strong pipeline of early career technology talent, and create equitable opportunities for underrepresented students, Evernorth has partnered with Access Point – a program designed to provi...
Read MoreExpress Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Read More
Leveraging biosimilars to drive savings and support patient access
By the end of 2023, 11 biosimilars for Humira will be available for patients living with inflammatory conditions, enabling lower costs for a drug class that currently represents nearly 25% of total dr...
Read More